Natera (NTRA) EBIT Margin (2014 - 2026)
Natera's (NTRA) quarterly EBIT Margin came in at 10.07% in Q2 2026, up 1012.0% on a YoY basis from 0.91% in Q2 2025, and up 24.99% quarter-over-quarter from 13.42% in Q1 2026.
Powered by 
Analysis
Natera (NTRA) EBIT Margin (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported EBIT Margin for 13 consecutive years, with 10.07% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBIT Margin rose 1012.0% year-over-year to 10.07%; the trailing twelve-month figure through Jun 2026 stood at 10.7% (up 425.0% YoY), and the FY2025 full-year result was 13.44%, down 34.0% from the prior year.
- EBIT Margin climbed to 10.07% in Q2 2026 per NTRA's latest filing, from 13.42% in the prior quarter.
- Across five years, EBIT Margin topped out at 3.42% in Q4 2025 and bottomed at 72.19% in Q2 2022.
- Historically, EBIT Margin has averaged 31.45% across 5 years, with a median of 20.2% in 2024.
- The widest YoY moves for EBIT Margin: up 3847 bps in 2022, down 2926 bps in 2022.
- Over 5 years, EBIT Margin stood at 65.26% in 2022, then surged by 58 bps to 27.17% in 2023, then soared by 50 bps to 13.6% in 2024, then jumped by 75 bps to 3.42% in 2025, then tumbled by 194 bps to 10.07% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 10.07%, 13.42%, and 3.42% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -10.07% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 12.10% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 5.03% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | -22.04% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | -1.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.07% |
| Mar 31, 2026 | -13.42% |
| Dec 31, 2025 | -3.42% |
| Sep 30, 2025 | -16.48% |
| Jun 30, 2025 | -20.19% |
| Mar 31, 2025 | -15.78% |
| Dec 31, 2024 | -13.60% |
| Sep 30, 2024 | -8.95% |
| Jun 30, 2024 | -10.62% |
| Mar 31, 2024 | -20.21% |
| Dec 31, 2023 | -27.17% |
| Sep 30, 2023 | -41.36% |
| Jun 30, 2023 | -43.01% |
| Mar 31, 2023 | -57.21% |
| Dec 31, 2022 | -65.26% |
| Sep 30, 2022 | -56.52% |
| Jun 30, 2022 | -72.19% |
| Mar 31, 2022 | -70.64% |
| Dec 31, 2021 | -80.72% |
| Sep 30, 2021 | -94.99% |